GOLIMUMAB INHIBITS PROGRESSION OF RADIOGRAPHIC DAMAGE IN PATIENTS WITH PSORIATIC ARTHRITIS: 52 WEEK RESULTS FROM THE GO-REVEAL STUDY

被引：0

作者：

Kavanaugh, A. ^{[1
]}

van der Heijde, D. ^{[2
]}

Chattopadhyay, Chandra

Gladman, D. ^{[3
]}

Mease, P. ^{[4
]}

McInnes, I. ^{[5
]}

Krueger, G. G. ^{[6
]}

Xu, W. ^{[7
]}

Rahman, M. U. ^{[8
,9
]}

Zrubek, J. ^{[8
]}

Baratelle, A. ^{[8
]}

Beutler, A.

机构：

[1] Univ Calif San Diego, La Jolla, CA 92093 USA

[2] Leiden Univ, Med Ctr, Leiden, Netherlands

[3] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada

[4] Univ Washington, Swedish Med Ctr, Seattle, WA 98195 USA

[5] Univ Glasgow, Glasgow, Lanark, Scotland

[6] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA

[7] Centocor Res & Dev Inc, Biostat, Malvern, PA USA

[8] Centocor Res & Dev Inc, Immunol, Malvern, PA USA

[9] Univ Penn, Sch Med, Philadelphia, PA 19104 USA

来源：

RHEUMATOLOGY | 2011年 / 50卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：143 / 143

页数：1

共 50 条

[21] Effects of golimumab on the dermatologic manifestations of psoriatic arthritis: 5-year results from the long-term extension of the randomized, placebo-controlled, GO-REVEAL study
Krueger, G. G.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB199 - AB199
[22] GOLIMUMAB, A NEW, HUMAN, TNF ALPHA ANTIBODY, ADMINISTERED SUBCUTANEOUSLY EVERY 4 WEEKS IN PSORIATIC ARTHRITIS PATIENTS: 104-WEEK EFFICACY AND SAFETY RESULTS OF THE RANDOMIZED, PLACEBO-CONTROLLED GO-REVEAL STUDY
Gladman, D.
Kavanaugh, A.
Mease, P.
Krueger, G. G.
Zrubek, J.
Beutler, A.
Hsu, B.
Mudivarthy, S.
Mack, M.
McInnes, I. B.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : 619 - 619
[23] GOLIMUMAB TREATMENT INHIBITS PROGRESSION OF JOINT DAMAGE IN PATIENTS WITH PSORIATIC ARTHRITIS REGARDLESS OF BASELINE DISEASE SEVERITY
Kavanaugh, Arthur
Gladman, Dafna
Chattopadhyay, Chandrabhusan
Beutler, Anna
Han, Chenglong
RHEUMATOLOGY, 2012, 51 : 69 - 69
[24] Golimumab Treatment Inhibits Progression in Joint Damage in Patients with Psoriatic Arthritis Regardless of Baseline Disease Severity
Kavanaugh, Arthur
Gladman, Dafna D.
Beutler, Anna
Han, Chenglong
ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S861 - S861
[25] Golimumab Treatment Inhibits Progression in Joint Damage in Patients with Psoriatic Arthritis Regardless of Baseline Disease Severity
Kavanaugh, Arthur
Gladman, Dafna
Beutler, Anna
Han, Chenglong
Chandran, Vinod
JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) : 1736 - 1737
[26] Etanercept (ENBREL®) inhibits radiographic progression in patients with psoriatic arthritis
Ory, P
Sharp, JT
Salonen, D
Rubenstein, JD
Mease, PJ
Ruderman, EM
Kivitz, AJ
Burge, DJ
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 92 - 93
[27] Golimumab, a new, human, TNF-alpha antibody administered as a monthly subcutaneous injection in psoriatic arthritis:: 24-week efficacy and safety results of the randomized, placebo-controlled GO-REVEAL study
Kavanaugh, Arthur
McInnes, Lain
Mease, Philip
Krueger, Gerald G.
Gladman, Dafna
Gomez-Reino, Juan Jesus
Papp, Kim
Livingston, Julie
Mudivarthy, Surekha
Mack, Michael E.
Beutler, Anna
ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4308 - 4309
[28] Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study
Keystone, Edward
Genovese, Mark C.
Klareskog, Lars
Hsia, Elizabeth C.
Hall, Stephen
Miranda, Pedro C.
Pazdur, Jacek
Bae, Sang-Cheol
Palmer, William
Xu, Stephen
Rahman, Mahboob U.
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (06) : 1129 - 1135
[29] GOLIMUMAB AND RADIOGRAPHIC PROGRESSION IN RHEUMATOID ARTHRITIS: RESULTS OF GO-BEFORE AND GO-FORWARD STUDIES
Emery, P.
Fleischmann, R.
van der Heijde, D.
Keystone, E.
Genovese, M. C.
Conaghan, P. G.
Hsia, E. C.
Xu, W.
Baratelle, A.
Beutler, A.
Rahman, M. U.
RHEUMATOLOGY, 2011, 50 : 119 - 120
[30] Golimumab and Radiographic Progression in Rheumatoid Arthritis: Results of GO-BEFORE and GO-FORWARD Studies
Keystone, Edward
JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1293 - 1294

← 1 2 3 4 5 →